Manabu Inoue: Tenecteplase or Alteplase Before Thrombectomy by T-FLAVOR Trial
Manabu Inoue, Chief Medical Officer at Pharmaceuticals and Medical Devices Agency (PMDA), shared on LinkedIn about a recent article he and his colleagues co-authored, published in JAMA Neurology, adding:
”I am pleased to share that the T-FLAVOR trial has been published in JAMA Neurology.
T-FLAVOR is a multicenter, randomized clinical trial comparing tenecteplase with the approved Japanese low-dose alteplase (0.6 mg/kg) before endovascular thrombectomy in patients with acute ischemic stroke.
To our knowledge, this is the first randomized trial to evaluate these two thrombolytic strategies in Japan.
I am sincerely grateful to all investigators, study coordinators, patients, and their families for making this study possible.
I hope these findings will contribute to improving stroke care and advancing evidence-based treatment worldwide.”
Title: Standard-Dose Tenecteplase vs Low-Dose Alteplase for Acute Ischemic Stroke From Large-Vessel Occlusion. A Randomized Clinical Trial
Authors: Manabu Inoue, Teruyuki Hirano, Mayumi Fukuda-Doi, Hiroyuki Kawano, Kenta Tanaka, Nobuyuki Sakai, Masatoshi Koga, Koji Iwasaki, Tomohide Yoshie, Naruhiko Kamogawa, Masafumi Ihara, Tsuyoshi Ohta, Masaki Chin, Naoto Kimura, Kazumi Kimura, Yohei Tateishi, Tadashi Terasaki, Taketo Hatano, Takahiro Kuwashiro, Shinichi Yoshimura, Toshihiro Ueda, Eiichiro Nagata, Yoshinari Nagakane, Shinichi Takahashi, Fumio Miyashita, Kazutaka Sonoda, Kenji Fukuda, Kanta Tanaka, Yoshiko Une, Shigetaka Kobari, Takehiko Nagao, Makoto Sasaki, Haruko Yamamoto, Kazunori Toyoda for the T-FLAVOR trial Investigators

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?